Advancing Glaucoma Medical Therapies, Making MIGS Treatment Decisions, and Combining Procedures in the Context of Cataract Surgery | ASCRS
CME Activity
Advancing Glaucoma Medical Therapies, Making MIGS Treatment Decisions, and Combining Procedures in the Context of Cataract Surgery
September 2019

CME Activity Details

Activity Availability

This CME activity is available to all ophthalmologists. Click the button below to access this activity in the CME 24/7 portal. 

Begin Activity Now

Description

Enjoy this 60-minute CME activity in which a panel of experts discuss a range of solutions for glaucoma and combined procedures. Topics include glaucoma medical therapies, glaucoma in the context of cataract surgery, and the impact of non-compliance on treatment decisions.

CME Information

This activity is supported by educational grants from Aerie Pharmaceuticals, Santen Pharmaceuticals, Allergan, Bausch + Lomb, Glaukos Corporation, and Ivantis.
Credits
: By completing this activity you will earn 1.0 AMA PRA Category 1 Credits™.
Activity Expiration Date: November 30, 2020

Learning Objectives

Upon successful completion of this activity, participants should be able to:

  • Describe new and emerging options in glaucoma medical therapy, laser treatment, and MIGS
  • Determine how best to apply therapeutic options and treatment decisions for the patient who is (or is suspected to be) noncompliant with topical drops
  • Use scientific evidence and diagnostic information to guide timing and combination of procedures for reduction of IOP in the context of cataract surgery

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.